Following up on the last post, this is what the AllTrials campaign proposes [the document contains an Appendix with an outline of the specifics]: All trials registered. All results reported. September 2013 The AllTrials campaign calls for all past and present clinical trials to be registered and their results reported. Clinical trials are investigations designed […]
I expect many saw the recent report from Elizabeth Bradley at the Yale School of Public Health, The U.S. Health Care Paradox: How Spending More is Getting Us Less. If you haven’t seen it, take a look. It’s brief. The central point was in this graph: When I saw it, I copied the graph for […]
NASA VIDEO
Well chasing down the leads from the last post was disappointing. Brain Resource [the sponsor of iSPOT] does indeed have a data sharing plan, but it’s not sharing of a particular study like iSPOT. It’s a related but separate organization called BRAINnet. BRAINnet is a large database of neuroscientific data on both normal and a […]
Among the strange stories that will be told looking back on the second age of psycho·pharmacology, none will likely rival the quest to improve the efficacy of the SSRI and other antidepressants. As they rolled onto the market following Prozac’s introduction, there was an intense competition for market share, with the manufacturer of each new […]
In all of the offers of cooperation about data transparency in Clinical Trials that have been made by the pharmaceutical companies in response to the various campaigns, there is one deal-breaker at the core of every proposal: The pharmaceutical company itself chooses what is to be released That is, in fact, the problem in the […]
One pill makes you larger And one pill makes you small And the ones that mother gives you Don’t do anything at all… From Club to Clinic: Physicians Push Off-Label Ketamine as Rapid Depression Treatment Is Ketamine Right for You? Off-Label Prescriptions for Depression Pick Up in Small Clinics Ketamine, A Darling of the Club […]
Dear Friends Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The European Medicines Agency’s proposed policy on publishing and sharing information from clinical trials is open for comment until 30th September. Many of you have been involved in getting your organisations […]
Edmund Husserl was a German philosopher whose work separates the wheat from the chaff, and I’m definitely the latter, knowing next to nothing. I once knew a philosophy professor who was an expert, but all I ever heard him talk about was Husserl’s life and relationship with his assistant, Martin Heidegger. One more story – […]